{"id":8569,"date":"2014-06-04T12:11:35","date_gmt":"2014-06-04T10:11:35","guid":{"rendered":"http:\/\/medrazgl.si\/?p=8569"},"modified":"2017-11-29T18:02:57","modified_gmt":"2017-11-29T17:02:57","slug":"the-management-of-sezary-syndrome-patient","status":"publish","type":"post","link":"https:\/\/medrazgl.si\/en\/the-management-of-sezary-syndrome-patient\/","title":{"rendered":"The Management of S\u00e9zary Syndrome Patient"},"content":{"rendered":"<p>S\u00e9zary Syndrome is a rare leukemic cutaneous T-cell lymphoma with unknown etiology and an aggressive clinical course. It is characterized by erythroderma, generalized lymphadenopathy and neoplastic CD4+ memory T cells called S\u00e9zary cells in the skin, lymph nodes and peripheral blood. The early course of the disease is usually misdiagnosed because skin lesions may be atypical for several years because they mimic other more common benign skin diseases, including atopic dermatitis. For this reason we must carry out further investigations on patients with erythroderma and higher levels of IgE to confirm cutaneous T-cell lymphoma. Histological findings, high CD4\/CD8 ratio and presence of S\u00e9zary cells in peripheral blood are helpful in reaching a correct diagnosis. The diagnostic process is made even more challenging because the histology is often nonspecific at the beginning and the median duration from the initial appearance of skin lesions to a diagnosis is almost six years. This complex phenotype is associated with a poor clinical outcome and a poor prognosis as an estimated survival rate of five years is only 25% after diagnosis. S\u00e9zary syndrome is currently incurable. In general, available therapies are effective in controlling the disease, but they have not been shown to prolong life, with the exception of treatment with methotrexate. The treatment of advanced stages of S\u00e9zary syndrome is a huge therapeutic challenge as there is no standard or definite curative treatment regimen. We present a case of a patient with confirmed S\u00e9zary syndrome three years after the first appearance of itchy, floury scaling and erythematous skin lesions. After extensive diagnostics and setting the stage of the disease, we started treating him with low doses of methotrexate.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>S\u00e9zary Syndrome is a rare leukemic cutaneous T-cell lymphoma with unknown etiology and an aggressive clinical course. It is characterized by erythroderma, generalized lymphadenopathy and neoplastic CD4+ memory T cells called S\u00e9zary cells in the skin, lymph nodes and peripheral blood. The early course of the disease is usually misdiagnosed because skin lesions may be [&hellip;]<\/p>\n","protected":false},"author":35,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[680,416],"tags":[],"class_list":["post-8569","post","type-post","status-publish","format-standard","hentry","category-1-2014-archive","category-dermatovenerology"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>The Management of S\u00e9zary Syndrome Patient - Dru\u0161tvo Medicinski razgledi<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/medrazgl.si\/obravnava-bolnika-s-sezaryjevim-sindromom\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"The Management of S\u00e9zary Syndrome Patient - Dru\u0161tvo Medicinski razgledi\" \/>\n<meta property=\"og:description\" content=\"S\u00e9zary Syndrome is a rare leukemic cutaneous T-cell lymphoma with unknown etiology and an aggressive clinical course. It is characterized by erythroderma, generalized lymphadenopathy and neoplastic CD4+ memory T cells called S\u00e9zary cells in the skin, lymph nodes and peripheral blood. The early course of the disease is usually misdiagnosed because skin lesions may be [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/medrazgl.si\/obravnava-bolnika-s-sezaryjevim-sindromom\/\" \/>\n<meta property=\"og:site_name\" content=\"Dru\u0161tvo Medicinski razgledi\" \/>\n<meta property=\"article:published_time\" content=\"2014-06-04T10:11:35+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2017-11-29T17:02:57+00:00\" \/>\n<meta name=\"author\" content=\"Matej Gori\u010dar\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Matej Gori\u010dar\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/medrazgl.si\\\/obravnava-bolnika-s-sezaryjevim-sindromom\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/medrazgl.si\\\/obravnava-bolnika-s-sezaryjevim-sindromom\\\/\"},\"author\":{\"name\":\"Matej Gori\u010dar\",\"@id\":\"https:\\\/\\\/medrazgl.si\\\/#\\\/schema\\\/person\\\/34d7ecbf2c9ebf96d826c5634daed7ca\"},\"headline\":\"The Management of S\u00e9zary Syndrome Patient\",\"datePublished\":\"2014-06-04T10:11:35+00:00\",\"dateModified\":\"2017-11-29T17:02:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/medrazgl.si\\\/obravnava-bolnika-s-sezaryjevim-sindromom\\\/\"},\"wordCount\":287,\"commentCount\":0,\"articleSection\":[\"1\",\"Dermatovenerology\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/medrazgl.si\\\/obravnava-bolnika-s-sezaryjevim-sindromom\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/medrazgl.si\\\/obravnava-bolnika-s-sezaryjevim-sindromom\\\/\",\"url\":\"https:\\\/\\\/medrazgl.si\\\/obravnava-bolnika-s-sezaryjevim-sindromom\\\/\",\"name\":\"The Management of S\u00e9zary Syndrome Patient - Dru\u0161tvo Medicinski razgledi\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/medrazgl.si\\\/#website\"},\"datePublished\":\"2014-06-04T10:11:35+00:00\",\"dateModified\":\"2017-11-29T17:02:57+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/medrazgl.si\\\/#\\\/schema\\\/person\\\/34d7ecbf2c9ebf96d826c5634daed7ca\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/medrazgl.si\\\/obravnava-bolnika-s-sezaryjevim-sindromom\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/medrazgl.si\\\/obravnava-bolnika-s-sezaryjevim-sindromom\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/medrazgl.si\\\/obravnava-bolnika-s-sezaryjevim-sindromom\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/medrazgl.si\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"The Management of S\u00e9zary Syndrome Patient\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/medrazgl.si\\\/#website\",\"url\":\"https:\\\/\\\/medrazgl.si\\\/\",\"name\":\"Dru\u0161tvo Medicinski razgledi\",\"description\":\"Dru\u0161tvo Medicinski razgledi\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/medrazgl.si\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/medrazgl.si\\\/#\\\/schema\\\/person\\\/34d7ecbf2c9ebf96d826c5634daed7ca\",\"name\":\"Matej Gori\u010dar\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/003f8c4b027e5f6651eec48509adb56770581509ef227519d254087e28cffac3?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/003f8c4b027e5f6651eec48509adb56770581509ef227519d254087e28cffac3?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/003f8c4b027e5f6651eec48509adb56770581509ef227519d254087e28cffac3?s=96&d=mm&r=g\",\"caption\":\"Matej Gori\u010dar\"},\"url\":\"https:\\\/\\\/medrazgl.si\\\/en\\\/author\\\/matej-goricar\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"The Management of S\u00e9zary Syndrome Patient - Dru\u0161tvo Medicinski razgledi","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/medrazgl.si\/obravnava-bolnika-s-sezaryjevim-sindromom\/","og_locale":"en_US","og_type":"article","og_title":"The Management of S\u00e9zary Syndrome Patient - Dru\u0161tvo Medicinski razgledi","og_description":"S\u00e9zary Syndrome is a rare leukemic cutaneous T-cell lymphoma with unknown etiology and an aggressive clinical course. It is characterized by erythroderma, generalized lymphadenopathy and neoplastic CD4+ memory T cells called S\u00e9zary cells in the skin, lymph nodes and peripheral blood. The early course of the disease is usually misdiagnosed because skin lesions may be [&hellip;]","og_url":"https:\/\/medrazgl.si\/obravnava-bolnika-s-sezaryjevim-sindromom\/","og_site_name":"Dru\u0161tvo Medicinski razgledi","article_published_time":"2014-06-04T10:11:35+00:00","article_modified_time":"2017-11-29T17:02:57+00:00","author":"Matej Gori\u010dar","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Matej Gori\u010dar","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/medrazgl.si\/obravnava-bolnika-s-sezaryjevim-sindromom\/#article","isPartOf":{"@id":"https:\/\/medrazgl.si\/obravnava-bolnika-s-sezaryjevim-sindromom\/"},"author":{"name":"Matej Gori\u010dar","@id":"https:\/\/medrazgl.si\/#\/schema\/person\/34d7ecbf2c9ebf96d826c5634daed7ca"},"headline":"The Management of S\u00e9zary Syndrome Patient","datePublished":"2014-06-04T10:11:35+00:00","dateModified":"2017-11-29T17:02:57+00:00","mainEntityOfPage":{"@id":"https:\/\/medrazgl.si\/obravnava-bolnika-s-sezaryjevim-sindromom\/"},"wordCount":287,"commentCount":0,"articleSection":["1","Dermatovenerology"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/medrazgl.si\/obravnava-bolnika-s-sezaryjevim-sindromom\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/medrazgl.si\/obravnava-bolnika-s-sezaryjevim-sindromom\/","url":"https:\/\/medrazgl.si\/obravnava-bolnika-s-sezaryjevim-sindromom\/","name":"The Management of S\u00e9zary Syndrome Patient - Dru\u0161tvo Medicinski razgledi","isPartOf":{"@id":"https:\/\/medrazgl.si\/#website"},"datePublished":"2014-06-04T10:11:35+00:00","dateModified":"2017-11-29T17:02:57+00:00","author":{"@id":"https:\/\/medrazgl.si\/#\/schema\/person\/34d7ecbf2c9ebf96d826c5634daed7ca"},"breadcrumb":{"@id":"https:\/\/medrazgl.si\/obravnava-bolnika-s-sezaryjevim-sindromom\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/medrazgl.si\/obravnava-bolnika-s-sezaryjevim-sindromom\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/medrazgl.si\/obravnava-bolnika-s-sezaryjevim-sindromom\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/medrazgl.si\/en\/"},{"@type":"ListItem","position":2,"name":"The Management of S\u00e9zary Syndrome Patient"}]},{"@type":"WebSite","@id":"https:\/\/medrazgl.si\/#website","url":"https:\/\/medrazgl.si\/","name":"Dru\u0161tvo Medicinski razgledi","description":"Dru\u0161tvo Medicinski razgledi","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/medrazgl.si\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/medrazgl.si\/#\/schema\/person\/34d7ecbf2c9ebf96d826c5634daed7ca","name":"Matej Gori\u010dar","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/003f8c4b027e5f6651eec48509adb56770581509ef227519d254087e28cffac3?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/003f8c4b027e5f6651eec48509adb56770581509ef227519d254087e28cffac3?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/003f8c4b027e5f6651eec48509adb56770581509ef227519d254087e28cffac3?s=96&d=mm&r=g","caption":"Matej Gori\u010dar"},"url":"https:\/\/medrazgl.si\/en\/author\/matej-goricar\/"}]}},"_links":{"self":[{"href":"https:\/\/medrazgl.si\/en\/wp-json\/wp\/v2\/posts\/8569","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medrazgl.si\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medrazgl.si\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medrazgl.si\/en\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/medrazgl.si\/en\/wp-json\/wp\/v2\/comments?post=8569"}],"version-history":[{"count":0,"href":"https:\/\/medrazgl.si\/en\/wp-json\/wp\/v2\/posts\/8569\/revisions"}],"wp:attachment":[{"href":"https:\/\/medrazgl.si\/en\/wp-json\/wp\/v2\/media?parent=8569"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medrazgl.si\/en\/wp-json\/wp\/v2\/categories?post=8569"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medrazgl.si\/en\/wp-json\/wp\/v2\/tags?post=8569"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}